I've done some work with Glenn in the past. He is not the type to treat RHY as a lifestyle company. My understanding is that trial 7 is just taking some time, plus they found some issues in the biomarkers (which has been fixed). Whilst that has been happening I think there has been some work in the background to line up some ducks in a row.
I am waiting for a CR or the price to fall below 10c to get in. The long term potential and great mgmt (as been alluded to by a lot here) are great positives.
My advise to you all is just to wait it out. Or else sell so I can get in at 9.5c
GLTAH & DYOR
Ann: Appendix 4C - quarterly, page-38
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.34M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $2.291K | 20.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 23335 | 3 |
View Market Depth
| Last trade - 11.54am 08/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |